Immunotherapy: on the cutting edge of your latest inventions and innovations

Regimbeau is aware of the challenges and stakes of innovations in this field, and with the support of a dedicated team of technical and legal experts and its privileged network of expert foreign correspondents, Regimbeau brings you all the answers needed to define the protection strategy most suited to your invention and needs.

Our approach

Defining the best protection strategies and providing you with answers adapted to your specific needs

You are an academic research player, or a French or foreign company, and work in the field of:

  • immunotherapy: naked or drug-conjugated antibodies, immunomodulation (e.g. cytokines, immune checkpoint inhibitors), prophylactic or therapeutic vaccines, adoptive cell transfer therapies (e.g. CAR-T), etc.)
  • immunoanalysis, particularly as applied to diagnosis: tests involving antibodies, flow cytometry, immunohistochemistry, immunofluorescence, functional tests, etc.


TCR, CDR, Fc, Fab, ADC, ADCC, CDC, FACS, ELISA, ELISPOT… These acronyms hold no secrets for our experts at Regimbeau, who will help you and advise you on how to effectively protect all your inventions, even the most complex ones!

Patentability of antibodies and diagnostic or therapeutic methods, SPCs, biosimilars, specific regulatory requirements… Regimbeau’s teams keep abreast of the latest developments relating to the protection of these inventions, not only in France but also in Europe and internationally.

Our interventions

Identifying, securing and promoting your immunotherapy-related innovations

  • Protecting your innovations, in line with your strategic goals, while considering your schedule and budget. Regimbeau’s team works closely with your experts to define the protection that best meets your needs.
  • Drafting strong patents, with optimised scope depending on the territories, calling on multiple skills where appropriate to protect inventions in complex fields such as bioinformatics or antibody design aided by artificial intelligence.
  • Protecting health data collected as part of a clinical trial to consolidate your product coverage.
  • Taking into account the regulatory timetable in defining and optimising a protection strategy, in particular by taking out complementary protection certificates.
  • Enhancing the value of your industrial property portfolio, an important asset of your company.
  • Convincing investors of the protection of your innovations and your freedom to operate, for example in the context of capital raising.
  • Securing the chain of rights to avoid any (un)pleasant surprises at the time of an audit, transfer or concession of your assets.
  • Advising you on the defence of your rights, with respect to your strategic interests.
  • Assisting you in litigation and pre-litigation situations, to ensure that your rights are respected.
  • Implementing technological and competitive monitoring, thus allowing you to identify your areas of development while also monitoring your competitors’ activities.
  • Regimbeau regularly organises and participates in events in Paris and in other French regions. Regimbeau is notably a partner of the MabDesign association, a specialist in immunotherapy and therapeutic antibodies.
Take an appointment

Are you looking to review your project and obtain guidance on the management of your strategic assets ?

Contact us